This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal
Resources

Kerendia®▼(finerenone) Short Videos

Kerendia Logo page image
Keeping Up With The Kidneys (KUWTK) Renal Meeting

  • Learn about the pivotal role primary care can play in the management of CKD with a focus on integration across primary and secondary care boundaries.

    Prescribing information for Kerendia®▼(finerenone) can be found here.

Diabetic Kidney Disease in Scotland: Dr Kevin Fernando & Professor Patrick Mark

The burden of CKD and the importance of UACR testing

Watch Dr Kevin Fernando and Professor Patrick Mark discuss guidelines for CKD with a focus on Scotland including why early detection and intervention is key.

Prescribing information for Kerendia®▼(finerenone) can be found here.

  • Discover the critical role of UACR, and how it can be used to aid early identification of CKD.

    Prescribing information for Kerendia®▼(finerenone) can be found here.

  • Join Dr Kieran McCafferty as he provides an overview of the Phase 3 FIDELIO -DKD study.

    Prescribing information for Kerendia®▼(finerenone) can be found here.

Related Content
Kerendia®▼ (finerenone)​ and the Kidneys
Breaking Barriers in CKD Management; short video series
PP-KER-GB-0798, February 2024
Nephrology Homepage
Explore Our Nephrology Hub
PP-KER-GB-0597, February 2024
Kerendia®▼ (finerenone) Primary Care Resources
Access useful, downloadable nephrology resources for HCPs in primary care.
RP-KER-GB-1106, February 2025

CKD=chronic kidney disease; MOD=mechanism of disease; MOA=mechanism of action.

PP-KER-GB-0566 I March 2024